Originally published by our sister publication Pain Medicine News
On January 15, the Drug Enforcement Administration’s long-awaited rules on telehealth prescribing of controlled substances were released. The regulatory updates include changes that allow patients to receive a 6-month supply of buprenorphine treatment through a phone consultation.
Following the 6-month period, patients will be required to visit a medical provider in person or via other forms of telemedicine. The new rule also